Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Gains from Investment Securities (2021 - 2024)

Bio Essence (BIOE) has 4 years of Gains from Investment Securities data on record, last reported at $3812.0 in Q2 2024.

  • For Q2 2024, Gains from Investment Securities changed N/A year-over-year to $3812.0; the TTM value through Dec 2024 reached $800.0, down 99.95%, while the annual FY2024 figure was $800.0, 99.95% down from the prior year.
  • Gains from Investment Securities reached $3812.0 in Q2 2024 per BIOE's latest filing, up from -$3012.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.6 million in Q3 2023 and bottomed at -$3012.0 in Q1 2024.
  • Average Gains from Investment Securities over 4 years is $318172.6, with a median of $3300.0 recorded in 2021.